{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/TNXP",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nTonix Pharmaceuticals Holding Corp. is listed on NASDAQ under ticker TNXP, ISIN US8902608392, LEI 529900ACPKP9QW20GX48. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Nevada. Segment is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 77 filings in the twelve months to 2026-11-08, across 53 filing days. The median gap between filing days is 5.5 days. The latest filing is a results filing dated 2026-10-15, 24 days before the record date. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency. The 2834 Pharmaceutical Preparations sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency.\n\n## Auditor\n\nThe auditor is not on the record, because the latest annual report cover carries no auditor name tag. The record holds one auditor change, dated 2026-03-18. The auditor's location is not on the record.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change events. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as exchange tier transfers are not EDGAR filings. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names five research houses: TD Cowen, Raymond James, Alliance Global Partners, Canaccord Genuity and Zacks Small-Cap Research.\n\n## Open research\n\nNo openly published research notes are on the record. None was found.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds sealed annual years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001430306.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/TNXP (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ir.tonixpharma.com/stock-data/analyst-coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/TNXP (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": [
    {
     "date": "2026-03-18",
     "source": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126006169/tonix-8k_031826.htm",
     "title": "8-K — CURRENT REPORT (items 4.01,9.01)"
    }
   ]
  },
  "cmr": "us-cm-kg/NASDAQ/TNXP",
  "coverage": {
   "count": 5,
   "houses": [
    {
     "analyst": "Stacy Ku, PhD",
     "house": "TD Cowen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tonixpharma.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Tiago Fauth",
     "house": "Raymond James",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tonixpharma.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "James Molloy",
     "house": "Alliance Global Partners",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tonixpharma.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Gary Nachman",
     "house": "Canaccord Genuity",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tonixpharma.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "David Bautz, PhD",
     "house": "Zacks Small-Cap Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.tonixpharma.com/stock-data/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://ir.tonixpharma.com/stock-data/analyst-coverage",
     "result": "read: 5 of 10 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "agm_egm": 2,
    "corporate_news": 24,
    "director_change": 4,
    "directors_dealings": 23,
    "prospectus": 2,
    "regulatory_filing": 11,
    "results": 11
   },
   "cadence_median_gap_days": 5.5,
   "filing_days": 53,
   "filings": 77,
   "latency_days": 24,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-10-15",
     "source": "https://www.sec.gov/Archives/edgar/data/1430306/000149315226047139/form8-k.htm",
     "title": "8-K — 8-K (items 2.02,8.01)",
     "type": "results"
    },
    {
     "category": "8-K",
     "date": "2026-10-02",
     "source": "https://www.sec.gov/Archives/edgar/data/1430306/000149315226045603/form8-k.htm",
     "title": "8-K — 8-K (items 8.01)",
     "type": "corporate_news"
    },
    {
     "category": "8-K",
     "date": "2026-09-22",
     "source": "https://www.sec.gov/Archives/edgar/data/1430306/000149315226043644/form8-k.htm",
     "title": "8-K — 8-K (items 8.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "8-K",
     "date": "2026-09-08",
     "source": "https://www.sec.gov/Archives/edgar/data/1430306/000149315226041689/form8-k.htm",
     "title": "8-K — 8-K (items 8.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "3",
     "date": "2026-09-08",
     "source": "https://www.sec.gov/Archives/edgar/data/1430306/000149315226041688/xslF345X06/ownership.xml",
     "title": "3 — 3",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-10-15",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/TNXP",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US8902608392"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001430306.json",
    "state": "sourced",
    "value": "United States — Nevada"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US8902608392)",
    "state": "sourced",
    "value": "529900ACPKP9QW20GX48"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001430306.json",
    "state": "sourced",
    "value": "Tonix Pharmaceuticals Holding Corp."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001430306.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001430306.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "TNXP"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:799a16fde6e52ff8b5b1199902c687f248343197d2a036fa88d603f7c63862b1",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/TNXP",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:799a16fde6e52ff8b5b1199902c687f248343197d2a036fa88d603f7c63862b1",
 "path": "/us/NASDAQ/TNXP",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Tonix Pharmaceuticals Holding Corp. is listed on NASDAQ under ticker TNXP, ISIN US8902608392, LEI 529900ACPKP9QW20GX48. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Nevada. Segment is not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 77 filings in the twelve months to 2026-11-08, across 53 filing days. The median gap between filing days is 5.5 days. The latest filing is a results filing dated 2026-10-15, 24 days before the record date. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency. The 2834 Pharmaceutical Preparations sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, because the latest annual report cover carries no auditor name tag. The record holds one auditor change, dated 2026-03-18. The auditor's location is not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change events. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as exchange tier transfers are not EDGAR filings. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names five research houses: TD Cowen, Raymond James, Alliance Global Partners, Canaccord Genuity and Zacks Small-Cap Research.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes are on the record. None was found.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds sealed annual years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001430306.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/TNXP"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://ir.tonixpharma.com/stock-data/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/TNXP"
  }
 ],
 "title": "Tonix Pharmaceuticals Holding Corp. (TNXP) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}